- Home
- MDCX vs VNRX Comparison
MDCX vs VNRX Comparison
Compare MDCX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDCX | VNRX |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 35.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDCX | VNRX |
|---|---|---|
| Price | $0.95 | $0.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $23.50 | $2.50 |
| AVG Volume (30 Days) | 375.5K | ★ 2.1M |
| Earning Date | 03-27-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,472,007.00 |
| Revenue This Year | N/A | $55.98 |
| Revenue Next Year | N/A | $420.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $0.99 | $0.22 |
| 52 Week High | $8.94 | $0.94 |
Technical Indicators
Market Signals| Indicator | MDCX | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 21.00 | 36.48 |
| Support Level | $1.09 | $0.24 |
| Resistance Level | $1.29 | $0.28 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 1.17 | 5.64 |
Price Performance
Historical ComparisonAbout MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.